Search
for
Sort by
Research 151–180 of 1000+
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- THE USE OF AN IMMUNOMODULATOR WITH AN ANTISEPTIC IN THE TREATMENT OF INFECTED AND PURULENT WOUNDS IN AN EXPERIMENT
- THE COVID- 19 VACCINATION: AUTOIMMUNE PHENOMENON ALOPECIA AREATA
- Targeting integrin pathways: mechanisms and advances in therapy
- Correlation Between Interest in COVID-19 Hair Loss and COVID-19 Surges: Analysis of Google Trends
- Regulatory T cells in dominant immunologic tolerance
- Generation of human-induced pluripotent stem cell-derived adherent 3-dimensional skin hair-follicle organoids
- Polymorphism of genes in patients with new coronavirus infection COVID-19
- Alopecia Areata: An Updated Review for 2023
- COVID-19 infection is a major cause of acute telogen effluvium
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Alopecia Areata after COVID-19 Vaccines
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial
- Human adipose tissue–derived mesenchymal stromal cells and their phagocytic capacity
- The Chemical and Pharmacological Research Progress on a Kind of Chinese Herbal Medicine, Fructus Malvae
- Protein Microarrays
- Endocrinology
- Post-COVID-19 syndrome among hospitalized COVID-19 patients: a cohort study assessing patients 6 and 12 months after hospital discharge
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- Evaluating the Role of Thyroid Stimulating Hormone and Ferritin Levels with Hair Loss among Patients with COVID-19: Case-Control Study